An Ophthalmic Safety Study in Patients With Breast Cancer

Part of paid clinical trials in La Jolla, California.

Sponsor
AstraZeneca
Study ID
NCT06767462
Status
Recruiting
Apply to this trial

Conditions

  • Ophthalmic Safety in Patients With Breast Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - 130 Years
Healthy Volunteers
Not accepted

Study Details

To assess ophthalmic health in parallel cohorts of patients with breast cancer

Key Dates

Start date
Mar 4, 2025
Status verified
Jul 2025
Primary completion
Jul 6, 2027
Completion
Jul 6, 2027

Study Design

Enrollment
160 participants (estimated)

Arms

  • Arm: Cohort 1 from Qualifying Study
  • Arm: Cohort 2 from Qualifying Study

Primary Outcome Measure

Visual Acuity Testing (Snellen units) [ Time Frame: Ophthalmic review by central reader until 28 days after End of Study visit. ]

Central Contacts

Locations (12)

FacilityCityStateZIPSite coordinators
Research SiteLa JollaCalifornia92093-
Research SitePalo AltoCalifornia94304-
Research SiteSan DiegoCalifornia92123-
Research SiteIowa CityIowa52242-
Research SiteNew YorkNew York10029-
Research SiteWinston-SalemNorth Carolina27104-
Research SiteClevelandOhio44195-
Research SiteClairtonPennsylvania15025-
Research SitePittsburghPennsylvania15219-
Research SiteSioux FallsSouth Dakota57105-
Research SiteBartlettTennessee38133-
Research SiteHoustonTexas77030-

Find similar trials in La Jolla, CA

By research site
Research Site· La Jolla, CAResearch Site· Palo Alto, CAResearch Site· San Diego, CAResearch Site· Iowa City, IAResearch Site· New York, NYResearch Site· Winston-Salem, NC